Clinicopathological Features Among Patients With Advanced Human Epidermal Growth Factore-2-Positive Breast Cancer With Prolonged Clinical Benefit to First-Line Trastuzumab-Based Therapy: A Retrospective Cohort Study
AuthID
P-006-900
P-006-900